rs1805087, MTR

N. diseases: 135
Source: ALL
Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Malignant Neoplasms
CUI: C0006826
Disease: Malignant Neoplasms
0.060 GeneticVariation BEFREE Irrespective of cancer status, several SNPs were found to be associated with altered serum folate concentrations, including the D919G SNP in methionine synthase (MTR), the L474F SNP in serine hydroxymethyl transferase 1 (SHMT1) and the V175M SNP in phosphatidyl ethanolamine methyltransferase (PEMT). 29474406 2018
Malignant Neoplasms
CUI: C0006826
Disease: Malignant Neoplasms
0.060 GeneticVariation BEFREE Therefore, these findings demonstrate that MS A2756G polymorphism may not be a risk factor for hematological cancer. 29310321 2017
Malignant Neoplasms
CUI: C0006826
Disease: Malignant Neoplasms
0.060 GeneticVariation BEFREE The methionine synthase variant c.2756A>G is associated with various types of cancer. 25531253 2014
Malignant Neoplasms
CUI: C0006826
Disease: Malignant Neoplasms
0.060 GeneticVariation BEFREE Methionine synthase A2756G polymorphism and risk of colorectal adenoma and cancer: evidence based on 27 studies. 23593229 2013
Malignant Neoplasms
CUI: C0006826
Disease: Malignant Neoplasms
0.060 GeneticVariation BEFREE Our study indicates that MTR A2756G polymorphism is a candidate gene polymorphism for cancer susceptibility regardless of environmental factors. 19826453 2010
Malignant Neoplasms
CUI: C0006826
Disease: Malignant Neoplasms
0.060 GeneticVariation BEFREE The current study suggests that there is no association between MTR A2756G polymorphism and the CBS (844ins68) insertion polymorphism and cancer of the upper gastrointestinal tract. 17726616 2008